Live feed07:30:00·1hPRReleasevia QuantisnowPMGC Holdings Announces Term Sheet with Orbit2Orbit for NorthStrive Biosciences to Launch a Spaceflight Study of Its Myostatin and Activin A Assets, EL-22 and EL-32, Targeting Microgravity-Induced Muscle LossByQuantisnow·Wall Street's wire, on your screen.ELAB· PMGC Holdings Inc.Health Care